Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 3Withdrawn 1Unknown 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 11Carcinoma, Ovarian Epithelial 4Small Cell Lung Carcinoma 2Neoplasms 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrent/ Advanced Stage Endometrial Cancer Patients 1Platinum-resistant Ovarian Cancer 1Pancreatic Neoplasms 1Ovarian Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Nausea 1Mesothelioma, Malignant 1Mesothelioma 1Melanoma 1Kenny-Caffey syndrome, Type 1 1Gonadal Disorders 1Glioblastoma 1Genital Neoplasms, Female 1Genital Diseases, Female 1Endometrial Neoplasms 1Endocrine System Diseases 1Endocrine Gland Neoplasms 1

Interventions

Paclitaxel 6Carboplatin 6Radiotherapy 5olaparib 4Surveys and Questionnaires 4Cisplatin 4Surgical Procedures, Operative 3Sentinel Lymph Node Biopsy 3Metformin 3pembrolizumab 2lenvatinib 2durvalumab 2dostarlimab 2anlotinib 2Reverse Transcriptase Polymerase Chain Reaction 2Progesterone 2Magnetic Resonance Spectroscopy 2Injections 2High-Energy Shock Waves 2Hematologic Tests 2Genetic Testing 2Docetaxel 2Blood Specimen Collection 2Base Sequence 2Amplified Fragment Length Polymorphism Analysis 2vistusertib 1serabelisib 1pazopanib 1palbociclib 1onapristone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Endometrial Neoplasms × niraparib × Clear all
NCT03016338 2024-01-30

Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer

University Health Network, Toronto

Phase 2 Unknown
51 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡